About Avolve


Avolve is the European brand name for Dutasteride, the oral medicine made by GlaxoSmithKline for treating symptomatic benign prostatic hyperplasia (BPH) in men.

The medicine has also shown excellent results in treating and helping reverse genetic male pattern hair loss on the vertex (top of the head) and the mid-scalp area. Early results from clinical trials show Avolve's effectiveness compared with Propecia.

Avolve is approved by the US Food & Drug Administration, and in Europe, for treating BPH. Avolve is supplied in 0.5mg soft gelatin capsules. The version of the treatment available in the US has the brand name Avodart.